Dr. Georges Benjamin, executive director of the American Public Health Association, says the legislative agreement for $10 billion in new federal COVID funding is “really a drop in the bucket.” He says more dollars are needed to build up public health in all parts of the U.S. He responded to some political complaints by assuring taxpayers that public health officials are indeed financially accountable.

Conversations on Health Care hosts Mark Masselli and Margaret Flinter also asked Dr. Benjamin about the reorganization plans for the Centers for Disease Control and Prevention; he says it needs a greater focus on emergency preparedness.

Dr. Mary Bassett, New York State Commissioner of Health, says the COVID Omicron variant is still exposing health inequities — African Americans in New York have been hospitalized twice as much as the majority population during this latest wave. Bassett says achieving health equity “will be the North Star of my working life as a physician committed to public health.” Bassett also tells Conversations on Health Care hosts Mark Masselli and Margaret Flinter that the state has four times as many hospitalized now compared to the pandemic lull last summer. Yet she also notes the hospitalization and case rates are going down.

This week, hosts Mark Masselli and Margaret Flinter welcome Dr. Anthony Fauci back to the show, two years after his first appearance discussing the novel coronavirus spreading around the world. The Chief Medical Advisor to the Biden White House and long-time Director of the National Institute for Allergy and Infectious Diseases at the NIH expressed concern over the ongoing political divisiveness impacting our ability to contain COVID outbreaks leading to almost 1 million deaths in this country. He says FDA approval of the mRNA vaccine for young children will likely come on the heels of better data on efficacy with a third dose. He still marvels at the dramatic scientific achievement of the swift development and deployment of an effective vaccine against a challenging new pathogen, which he said would not have happened without decades of committing our resources to scientific research.

Dr. Cameron Webb, White House Senior Policy Adviser for COVID-19 Equity, is navigating a tricky situation — as he advocates for vaccines, the university where he works just dropped its student vaccine mandate. Webb tells Conversations on Health Care hosts Mark Masselli and Margaret Flinter that he realizes the University of Virginia has some new dynamics to navigate. “There’s this rush to roll back a lot of the strategies that have gotten us to a point where we’re seeing less death,” he says. “This pandemic has been politicized to a point that it’s indistinguishable from the rest of our political rhetoric…rhetoric often meant to motivate a voter base.” Webb also discusses the administration’s efforts to address COVID equity issues, including the need to collect better data about race and ethnicity vaccination rates.

This week hosts Mark Masselli and Margaret Flinter speak with Congresswoman Rosa DeLauro (D-CT), Chair of the House Appropriations Committee, on her expectations for building consensus on revised Build Back Better legislation, as well as the possibility for more relief money for hospitals and other entities in the wake of the ongoing pandemic. She says the expanded Child Tax Credit has lifted millions of American children out of poverty, significantly easing economic pressures on working families, and that it should be restored. Representative DeLauro also discusses the President’s infrastructure law, which she says will have a dramatic impact on the nation’s aging transportation and clean water delivery systems, as well as create new jobs.

This week hosts Mark Masselli and Margaret Flinter welcome US Education Secretary Dr. Miguel Cardona, who discusses the Biden administration’s efforts to contain the pandemic’s impact while keeping students and teachers safe in school. He laments the influence of politics on the proven public health practices to prevent spread of the disease which includes mask wearing and widespread vaccinations. He says this pandemic has revealed the importance of providing medical and behavioral care in school-based health clinics. He also applauds First Lady Jill Biden’s thoughtful advice on education policy as a veteran of the education system.

This week, hosts Mark Masselli and Margaret Flinter welcome renowned epidemiologist Dr. Michael Osterholm, Director of the Center for Infectious Disease Research and Policy (CIDRAP) at the University of Minnesota, who has served 5 presidential administrations in preparing for pandemics and bio-terror threats. Dr. Osterholm says the highly infectious omicron variant will continue to threaten hospital systems, schools and supply chains, warning the threat of future variants that may evade immunity is still a very real concern. He predicts that a combination of improved vaccines and new therapeutics will render COVID more manageable in the future, but that we will have to learn to 'live with it'.

This week, hosts Mark Masselli and Margaret Flinter welcome CDC Director Dr. Rochelle Walensky, addressing confusion and frustration around lack of rapid COVID tests and need for more N95 masks for the public. She talks about the shifting plan of action from the Biden Administration in response to the dramatic surge in omicron-driven COVID cases, and the scaled up efforts to make rapid tests and high quality masks available to all Americans.

This week, hosts Mark Masselli and Margaret Flinter speak with Dr. Zeke Emanuel, Vice Provost at the University of Pennsylvania and former member of the Biden administration’s COVID Transition Team. He and other former Biden advisors have called for a dramatic new approach to addressing COVID-19 saying we will not eradicate the virus, so we need new strategies to live with it. They’re calling for a radical re-tooling of our public health data system to capture real-time data, and for a significant investment in community health workers to address public health challenges on the ground.

This week, hosts Mark Masselli and Margaret Flinter speak with Dr. Peter Hotez, Dean of the National School of Tropical Medicine at the Baylor College of Medicine, and co-creator of a new, low-cost vaccine for COVID-19. Dr. Hotez discusses plans for Corbevax, a recombinant protein vaccine shown to be highly protective against COVID-19, which has just been given Emergency Use Authorization by the Indian government. Dr. Hotez’s plan is to make the formula available to poor and developing countries around the world, without any expectation of payment, to accelerate the pace of global vaccinations and bring the pandemic to an end. He also offers important advice to families with children navigating the omicron surge while heading back to school.

This week, Mark and Margaret take a look back at COVID’s hold on 2021, the early promise of vaccines, the relentless march of mutations and the vicious rise of new variants leading to pandemic surges around the world. They revisit conversations with memorable guests from famed virologists and epidemiologists like Paul Offit and Michael Osterholm, to President Biden’s COVID team leaders Rochelle Walensky, Anthony Fauci and Rachel Levine. They revisited guests focused on other health news: Bill McKibben on climate change, and Planned Parenthood President Alexis McGill Johnson on the existential threat to women’s reproductive rights in the U.S. It was also a year to celebrate the dramatic discovery underway in the field of science, with Eric Topol, William Haseltine and NIH Director Francis Collins.

This week hosts Mark Masselli and Margaret Flinter speak with renowned virus expert Dr. William Haseltine who has ‘grave concerns’ about Merck’s oral COVID drug Malnupiravir, which recently won narrow approval from the FDA advisory panel. He says the drug unleashes ‘dangerous’ mutations that could evolve the virus beyond control. He’s also urging extreme caution as the highly infectious omicron variant is sweeping across the US, saying it could be as deadly as the delta variant and that boosters may offer only limited protection of 3 months. Dr Haseltine, who developed the Anthrax vaccine and is President of ACCESS Health International, says public health protocols of masking, rapid testing and social distancing should be put back in place during this next surge.

This week, hosts Mark Masselli and Margaret Flinter welcome famed AIDS Researcher Dr. Robert Gallo, co-discoverer of the HIV virus, which led to the first tests and treatments for AIDS. He is Director of the Institute for Human Virology at the University of Maryland School of Medicine and Co-founder of the Global Virus Network, a consortium of research centers of excellence in 66 countries around the world, a nongovernmental agency collaborating on emerging virus research. Dr. Gallo says their network of scientists knew early in the COVID-19 pandemic that the mRNA vaccines would be effective, but for a limited time, and that boosters will be required until the global outbreak is brought under control. He says it’s too soon to predict the full impact of the omicron variant, but that it is likely to overwhelm many countries.

This week hosts Mark Masselli and Margaret Flinter welcome Dr. Eric Topol, Director of the Scripps Research Translational Institute, for his perspective on the rapid spread of the Omicron variant. He says early data shows that it is highly transmissible, but apparently not more deadly. His greater concern is around the current Delta surge leading to more infections, low vaccination rates in developing countries leading to more variants, and the “abysmal” vaccination performance in the U.S. He says mRNA vaccines should be considered a 3-dose protocol, and that rapid testing and virus sequencing should be more broadly deployed to stop the spread of the virus.

ts Mark Masselli and Margaret Flinter examine the latest details about the omicron COVID variant, including the important role community health centers continue to play in the pandemic. In addition, we revisit their recent conversation with Planned Parenthood Federation of America President and CEO Alexis McGill Johnson on the Supreme Court hearing on the Mississippi law banning abortion after 15 weeks, posing the greatest threat to Roe v. Wade in half a century. She also talks about systematic efforts in many states limiting women's access to abortion, and examines the previous administration’s Title X abortion ‘gag’ rule, which seriously impeded access to reproductive health services, creating particular hardship for vulnerable women. She expects the conservative-leaning high court will ultimately rule to undermine Roe.

This week hosts Mark Masselli and Margaret Flinter welcome “the Nation’s Doctor,” US Surgeon General Dr. Vivek Murthy, Co-chair of President Biden’s White House COVID Task Force. Dr. Murthy explains the FDA’s latest approval for mixing vaccine brands for booster shots. He also addresses White House plans to roll out COVID vaccine support for the nation’s 5-11-year-olds pending FDA approval, and how vaccine requirements are ‘turbocharging’ vaccination rates. Dr. Murthy examines the growing crisis of unmet mental health needs, addiction, and overdose in this country, exacerbated by the pandemic. He also discusses an initiative he’s creating to address burnout in the health care profession.

This week we speak with Dr. Ofer Levy, Director of the Precision Vaccines Program at Boston Children’s Hospital, Professor of Pediatrics at Harvard Medical School and member of the FDA COVID Vaccine Advisory Panel. He talks about the recent decision to reject boosters for all recipients 16 and older, saying they didn’t have enough data for younger populations to make that recommendation. He says the review process for emergency authorization for young children aged 5-to-11 will be thorough, rigorous and transparent to the public. His team is also currently working on developing a COVID vaccine, as well as other vaccines that could be deployed for cancer and even opioid use disorder and fentanyl overdose.

This week, hosts Mark Masselli and Margaret Flinter speak with former FDA Commissioner Dr. Scott Gottlieb whose new book outlines America’s epic failure in our response to the pandemic, leading to more than 700,000 deaths. “Uncontrolled Spread: Why COVID-19 Crushed Us and How We Can Defeat the Next Pandemic” examines the inherent flaws at the Centers for Disease Control and Prevention and other public agencies that left us vulnerable to the raging pandemic. Dr. Gottlieb says the CDC and other agencies should be re-tooled to conduct more agile global disease surveillance, and that emerging therapeutics like Merck’s new oral COVID drug will be a game changer for treatment moving forward.

This week hosts Mark Masselli and Margaret Flinter speak with Dr. Michael Mina, Epidemiologist and member of the Center for Communicable Disease Dynamics at Harvard where they are taking a multi-disciplinary approach to tackling the ongoing pandemic. Dr. Mina has long been a proponent of making cheap, rapid, at-home COVID tests available to all Americans as a much more effective way to curtail the pandemic’s spread. He says these tests which have been deployed successfully in other countries, are almost 100 per cent effective in identifying potential infectious ‘super-spreaders’, and that government should classify them as a public health, not a medical, tool to allow for more swift production and deployment. He also discusses their efforts to build a global surveillance system for future disease outbreaks.

This week, hosts Mark Masselli and Margaret Flinter welcome Dr. Francis Collins, Director of the National Institutes of Health, who also mapped the human genome. Dr. Collins laments the politicization of the pandemic, noting that ‘culture wars are killing people’. He urges patience on vaccine approval for families of younger children heading back to school, confident that scientific rigor will ensure vaccine safety. Dr. Collins, an avowed person of faith, urges faith-based resisters to trust the science that produced this life saving vaccine. He also discusses one of the largest protocols ever launched by the NIH to uncover the mysteries around long COVID syndrome, which is impacting an increasing number of COVID survivors.